SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QLT PhotoTherapeutics (QLTI)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Hawkeye who wrote (733)11/16/1999 9:53:00 PM
From: Ian@SI  Read Replies (1) of 1321
 
Recently, stock for the companies undergoing subcommittee review have been halted for the full day. Results are usually made public shortly after the close of trading.

I'm not sure when the halt, if imposed, will be lifted. Certainly trading will resume Thursday, if not afterhours on Wednesday.

With the extremely positive Phase 3 trial results, and the lack of any other treatment option which preserves vision, I'm having a difficult time understanding the selloff this month. I suspect some broker's clients are going to be extremely annoyed with the rotten advice they were given.

In any case, I expect a major upward move once trading resumes.

JMHO,
Ian
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext